<p>(A) Cumulative release of mBMP from HAP-titanium implant in SBF is over 60% at 4 weeks. (B) Fluorescent images of an implant after incorporation with fluorescently labeled mBMP (top) and after 4-week incubation in simulated body fluid (SBF) (bottom).</p
To evaluate the inflammatory potential of implants a bioluminescent imaging assay was developed usin...
<p>The images showed that the rapid increase of bone ingrowth into the pores of titanium throughout ...
<p>The amount of BMP-2 measured by ELISA is shown as the cumulative release normalized to the contro...
<p>A: Control, DynaCT demonstrating that gap between the implant and host bone was still visible (wh...
<p>The release profile of BMP-2<sub>GFP</sub> from bone graft was conversely expressed as the retent...
Local sustained delivery of bioactive molecules from biomaterials is a promising strategy to enhance...
Biorelevant in vitro release/dissolution tests are designed to predict the in vivo behavior of a dru...
<p>The fluorescent labeling indicated that abundant new bone growth into the porous titanium and con...
<p>(A) IVIS images of bioluminescent GGT and GGTDBT composites at 4 and 8 weeks postimplantation int...
The purpose of this study was to develop and characterize a novel fluorescence-based retention assay...
<p>(<b>A</b>) Van Gieson’s Picric–Fuchsin stain of new bone formation around implants. Red indicates...
To evaluate the inflammatory potential of implants a bioluminescent imaging assay was developed usin...
Bone morphogenetic proteins (BMP's) are vital for bone and cartilage formation, where bone morphogen...
This photograph originally appeared in the 2013 Research student photography and image competition h...
There is a critical need to develop noninvasive, nondestructive methods for assessing the quality of...
To evaluate the inflammatory potential of implants a bioluminescent imaging assay was developed usin...
<p>The images showed that the rapid increase of bone ingrowth into the pores of titanium throughout ...
<p>The amount of BMP-2 measured by ELISA is shown as the cumulative release normalized to the contro...
<p>A: Control, DynaCT demonstrating that gap between the implant and host bone was still visible (wh...
<p>The release profile of BMP-2<sub>GFP</sub> from bone graft was conversely expressed as the retent...
Local sustained delivery of bioactive molecules from biomaterials is a promising strategy to enhance...
Biorelevant in vitro release/dissolution tests are designed to predict the in vivo behavior of a dru...
<p>The fluorescent labeling indicated that abundant new bone growth into the porous titanium and con...
<p>(A) IVIS images of bioluminescent GGT and GGTDBT composites at 4 and 8 weeks postimplantation int...
The purpose of this study was to develop and characterize a novel fluorescence-based retention assay...
<p>(<b>A</b>) Van Gieson’s Picric–Fuchsin stain of new bone formation around implants. Red indicates...
To evaluate the inflammatory potential of implants a bioluminescent imaging assay was developed usin...
Bone morphogenetic proteins (BMP's) are vital for bone and cartilage formation, where bone morphogen...
This photograph originally appeared in the 2013 Research student photography and image competition h...
There is a critical need to develop noninvasive, nondestructive methods for assessing the quality of...
To evaluate the inflammatory potential of implants a bioluminescent imaging assay was developed usin...
<p>The images showed that the rapid increase of bone ingrowth into the pores of titanium throughout ...
<p>The amount of BMP-2 measured by ELISA is shown as the cumulative release normalized to the contro...